Dharmesh Singh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dharmesh Singh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Abhijit Shirlal
Department of Medical Imaging Technology, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, India
1 shared publication - Dileep Kumar
Centre for Intelligent Signal & Imaging Research, Universiti Teknologi PETRONAS, 31750 Tronoh, Perak, Malaysia
1 shared publication - Priya Ps
Department of Radiodiagnosis and Imaging, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India
1 shared publication - Priyanka
Department of Medical Imaging Technology, Manipal College of Health Professions Manipal Manipal Academy of Higher Education
1 shared publication - Rajagopal Kadavigere
Department of Radiodiagnosis and Imaging, Kasturba Medical College Manipal Manipal Academy of Higher Education
1 shared publication - Saikiran Pendem
Department of Medical Imaging Technology, Manipal College of Health Professions Manipal Manipal Academy of Higher Education
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Biomedical Imaging
- Vol. 2025 (1)
Diagnostic Efficacy and Correlation of Intravoxel Incoherent Motion (IVIM) and Contrast‐Enhanced (CE) MRI Perfusion Parameters in Oncology Imaging: A Systematic Review and Meta‐Analysis
Background: Intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) is a noncontrast technique estimating diffusion and perfusion parameters via multiple b ‐values, essential for oncology imaging. However, there is limited collective evidence regarding the efficacy of IVIM in oncology imaging compared to contrast‐enhanced (CE) MRI perfusion techniques. This systematic review and meta‐analysis compared IVIM′s diagnostic accuracy and correlation with CE MRI perfusion techniques. Methods: Following PRISMA guidelines (PROSPERO‐registered), a literature search across five databases (PubMed, Scopus, Embase, Web of Science, and Cochrane Library) was conducted. Diagnostic metrics, including AUC, sensitivity, specificity, and correlation coefficients, were analyzed using a random‐effects model, with heterogeneity and publication bias assessed via I 2 statistics and Egger′s test. Results: Eighteen studies on breast, rectal, and brain cancers were analyzed. For breast cancer, IVIM showed 83.50% sensitivity and 81.24% specificity compared to dynamic contrast‐enhanced (DCE) MRI′s 88.04% sensitivity and 65.98% specificity. In rectal cancer, IVIM achieved 70.9% sensitivity and 56.2% specificity, outperforming DCE MRI′s 58.11% sensitivity and 72.49% specificity. For gliomas, IVIM demonstrated 92.27% sensitivity and 74.06% specificity compared to dynamic susceptibility contrast (DSC) MRI′s 95.71% sensitivity and 92.91% specificity. Correlations between IVIM and CE parameters were weak to moderate. Conclusion: IVIM demonstrated equal or superior diagnostic performance to CE MRI in breast cancer, rectal cancer, and gliomas, offering a noncontrast alternative. However, unclear parameter correlations warrant future studies focusing on IVIM protocol optimization based on perfusion regimes.
- 1 January 2025
- Published by Wiley in International Journal of Biomedical Imaging
- Vol. 2025 (1)
Open AccessDiagnostic Efficacy and Correlation of Intravoxel Incoherent Motion (IVIM) and Contrast‐Enhanced (CE) MRI Perfusion Parameters in Oncology Imaging: A Systematic Review and Meta‐Analysis
Background: Intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) is a noncontrast technique estimating diffusion and perfusion parameters via multiple b ‐values, essential for oncology imaging. However, there is limited collective evidence regarding the efficacy of IVIM in oncology imaging compared to contrast‐enhanced (CE) MRI perfusion techniques. This systematic review and meta‐analysis compared IVIM′s diagnostic accuracy and correlation with CE MRI perfusion techniques. Methods: Following PRISMA guidelines (PROSPERO‐registered), a literature search across five databases (PubMed, Scopus, Embase, Web of Science, and Cochrane Library) was conducted. Diagnostic metrics, including AUC, sensitivity, specificity, and correlation coefficients, were analyzed using a random‐effects model, with heterogeneity and publication bias assessed via I 2 statistics and Egger′s test. Results: Eighteen studies on breast, rectal, and brain cancers were analyzed. For breast cancer, IVIM showed 83.50% sensitivity and 81.24% specificity compared to dynamic contrast‐enhanced (DCE) MRI′s 88.04% sensitivity and 65.98% specificity. In rectal cancer, IVIM achieved 70.9% sensitivity and 56.2% specificity, outperforming DCE MRI′s 58.11% sensitivity and 72.49% specificity. For gliomas, IVIM demonstrated 92.27% sensitivity and 74.06% specificity compared to dynamic susceptibility contrast (DSC) MRI′s 95.71% sensitivity and 92.91% specificity. Correlations between IVIM and CE parameters were weak to moderate. Conclusion: IVIM demonstrated equal or superior diagnostic performance to CE MRI in breast cancer, rectal cancer, and gliomas, offering a noncontrast alternative. However, unclear parameter correlations warrant future studies focusing on IVIM protocol optimization based on perfusion regimes.